Medicenna Therapeutics Corp. reposted this
We’re pleased to share that Dr. Fahar Merchant, President and CEO of Medicenna Therapeutics, will be attending the 6th Glioblastoma Drug Development Summit in Boston, MA (Feb 18-20, 2025)! This premier industry event brings together leading experts in neuro-oncology, biotech, and pharma to discuss the latest breakthroughs in glioblastoma and CNS tumor treatments. As Medicenna continues to advance the fight against brain cancer, we look forward to engaging in meaningful discussions on novel therapies, immunotherapy, and drug development strategies. If you're attending, connect with us to explore potential collaborations! https://lnkd.in/g-v_6U3k #Biotech #NeuroOncology #CNS #Immunotherapy #CancerResearch #BrainCancer